What Did AIDS Come From? The Animal Origins of HIV

HIV, the virus that causes AIDS, came from closely related viruses called simian immunodeficiency viruses (SIVs) that naturally infect African primates. The jump from animal to human did not happen just once: at least four separate transmission events gave rise to different lineages of HIV-1, and several more produced HIV-2, a less widespread form of the virus found mainly in West Africa. The story behind these crossings involves millions of years of viral evolution, specific primate species in specific corners of the African continent, and a set of molecular hurdles the virus had to clear before it could thrive in a human body.

A Virus That Lives in Dozens of Primate Species

SIV is not a single virus. More than 40 distinct versions circulate among African primate species, from chimpanzees and gorillas to smaller monkeys like African green monkeys and sooty mangabeys.¹ Each version is adapted to its particular host, and the relationship between virus and host is ancient. A phylogeographic analysis using the isolation of primate populations across islands and continents estimated that SIV has been circulating in primates for at least 32,000 years.² And there are hints the true age is far greater: remnants of a lentivirus have been found embedded in the DNA of the gray mouse lemur, a small primate from Madagascar whose ancestors split from African primates at least 14 million years ago.³ Evidence of similar viral infiltration in a second lemur species reinforces the conclusion that primates and lentiviruses go back much further than the modern AIDS epidemic would suggest.⁴

Infection rates in the wild can be remarkably high. In many primate populations, a large fraction of adults carry their species’ version of SIV, and transmission is routine throughout their lifetimes. This is the deep reservoir from which human immunodeficiency viruses eventually emerged.

Where HIV-1 Came From

HIV-1, the type responsible for the vast majority of AIDS cases worldwide, did not arise from a single animal-to-human event. It is made up of four distinct groups, labeled M, N, O, and P, and each one represents a separate cross-species jump.

Group M is the one that matters most epidemiologically. It accounts for the global pandemic, infecting tens of millions of people. Genetic analyses trace it to SIVcpz, the version of SIV carried by chimpanzees, specifically a subspecies living in southeastern Cameroon.⁵ Group N, a far rarer lineage found in only a handful of people, also came from chimpanzees in Cameroon through a separate transmission event.⁵

Groups O and P took a different path. Researchers found that western lowland gorillas in Cameroon carry SIV strains very closely related to these two HIV-1 lineages. The gorillas themselves likely acquired their SIV from chimpanzees at some earlier point, and then passed it along to humans in separate events. Group O has spread epidemically in west central Africa and is estimated to have infected around 100,000 people. Group P has been identified in only a few individuals.⁶

So the picture for HIV-1 is not one catastrophic spillover but at least four, each from a different primate population in a different part of Cameroon. Only one of those four, group M, went on to fuel a global epidemic. The others remained geographically confined or vanishingly rare.

Where HIV-2 Came From

HIV-2 has its own, entirely separate animal origin. It came from sooty mangabeys, a monkey species found in West Africa. The sooty mangabey version of SIV, called SIVsmm, jumped to humans on multiple independent occasions.⁷ At least eight distinct HIV-2 groups (A through H) have been identified, each one representing a separate animal-to-human transmission.

HIV-2 tends to progress more slowly than HIV-1, is harder to transmit sexually, and remains concentrated in West Africa, particularly in countries like Guinea-Bissau, Senegal, and Côte d’Ivoire. Because of this, it has never caused a pandemic on the scale of HIV-1 group M. But the repeated crossings from sooty mangabeys to humans underscore how frequently this kind of spillover has occurred. The barrier between SIV in primates and HIV in humans is not some impregnable wall; it is more like a filter that most viral lineages fail to get through, but that some lineages, under the right conditions, manage to penetrate.

When the Virus Jumped to Humans

Molecular clock techniques allow researchers to estimate when HIV-1 group M began diversifying in human populations. By tracking the rate at which the virus accumulates mutations and running the clock backward, multiple studies converge on the early twentieth century. One analysis placed the mean common ancestor of group M sequences around 1922.⁸ Another, using a different computational approach, dated the radiation of group M to the 1930s.⁹ The actual animal-to-human transmission likely predates these estimates by some years, since the molecular clock captures when the virus started branching into subtypes in the human population, not necessarily the moment it first entered a person.

Physical evidence supports this timeline. The oldest known HIV-1 group M sequences come from archival tissue samples collected in what was then Léopoldville, Belgian Congo (now Kinshasa, Democratic Republic of the Congo). One is a blood sample from 1959 and the other a lymph node biopsy from 1960. The 1960 specimen was recovered from a Bouin’s-fixed, paraffin-embedded biopsy from an adult woman, and genetic analysis showed that HIV-1 was already substantially diverse in Kinshasa by that time.¹⁰ That level of diversity means the virus had been circulating and evolving in the local population for decades before these samples were taken.

How the Pandemic Left Central Africa

The geography of early HIV-1 group M is strikingly specific. Kinshasa sits at the center. It was, in the colonial era, the largest and most connected city in central Africa, linked by river transport to the interior where chimpanzees carrying SIVcpz lived. Phylogenetic studies and historical epidemiology point to Kinshasa as the place where the virus first established sustained human-to-human transmission and began diversifying into the subtypes that now circulate globally.¹¹

From Kinshasa, the virus traveled outward. One well-documented route traces subtype B, the lineage that dominates in the Americas and Europe. Phylogenetic reconstructions show that HIV-1 subtype B was introduced from Africa into the Caribbean region, specifically Haiti, around 1966, carried by human migration during a period when many Haitians worked in the newly independent Congo.¹² From Haiti, the virus reached the United States by the early 1970s, years before anyone recognized what it was. The first clinical descriptions of AIDS would not come until 1981, by which point the virus had been silently spreading for over a decade.

Other subtypes took different geographic routes. Subtype C, the most prevalent globally, spread extensively through southern and eastern Africa and into India. Subtype A moved through East Africa and parts of Eastern Europe. Each route was shaped by patterns of migration, trade, and social connection. But all roads lead back to central Africa and, ultimately, to chimpanzees in the forests of Cameroon.

Why SIV Doesn’t Cause AIDS in Its Natural Hosts

One of the more striking aspects of this story is that the original animal hosts of SIV generally do not get sick. Chimpanzees, African green monkeys, sooty mangabeys, and many other African primates can carry high levels of virus in their blood for their entire lives without developing anything resembling AIDS.¹³ The virus replicates actively, including in the gut where it destroys CD4+ T cells early in infection, yet the host’s immune system does not spiral into the chronic inflammation that characterizes HIV disease in humans.¹⁴

The key difference appears to be immune activation. In humans infected with HIV, the immune system remains chronically activated, constantly trying to fight the virus and producing systemic inflammation that gradually wears down the body’s defenses. In natural SIV hosts, the immune system essentially makes a truce with the virus. There is an early immune response, but it quiets down, and the chronic activation that drives disease in humans simply does not develop.¹⁴ Cell death by apoptosis in immune tissues is low, the architecture of lymph nodes and gut tissue stays intact, and overall immune function is preserved.

This tolerance is the product of tens of thousands of years (or more) of coevolution. The host adapted to the virus, and the virus adapted to the host, reaching a détente in which both can survive. When SIV crossed into humans, a species that had no such evolutionary history with the virus, that truce did not carry over. The human immune system treats HIV as a dire threat and mounts a chronic inflammatory response that, ironically, helps destroy the very immune cells the body needs to fight infection.

The Genetic Barriers SIV Had to Clear

Jumping from one primate species to another is not easy for a virus. Mammalian cells have built-in antiviral proteins that can block retroviruses from replicating. One of the most important is called APOBEC3G, an enzyme that introduces lethal mutations into viral DNA during replication. Different primate species carry different versions of APOBEC3G, and a virus adapted to evade one species’ version may be crippled by another’s.

Research on rhesus macaques, a primate species that is not a natural SIV host, illustrates this barrier vividly. Macaques carry multiple distinct forms of APOBEC3G, and experiments showed that the version of SIV that eventually adapted to macaques (SIVmac, widely used in laboratory AIDS research) had to evolve specific countermeasures to get past this defense before it could cause disease.¹⁵ A similar process would have been necessary when SIVcpz from chimpanzees adapted to human cells. The virus had to find a way to counter human APOBEC3G and other restriction factors before it could replicate efficiently enough to establish a lasting infection.

This genetic barrier helps explain why cross-species jumps are rare even when human exposure to SIV is frequent. The virus has to land in a person, evade the host’s antiviral defenses, replicate well enough to establish chronic infection, and then transmit onward to other humans. Most exposures are dead ends. The handful that succeeded happened to involve viral variants that could clear all of these hurdles.

The Contaminated Vaccine Theory and Why It Was Rejected

In the late 1990s and early 2000s, journalist Edward Hooper promoted the idea that HIV-1 entered humans through contaminated oral polio vaccines prepared using chimpanzee kidney cells and administered in central Africa in the late 1950s. The theory attracted significant media attention and prompted direct investigation. Researchers tested wild chimpanzees from the specific region where the vaccine had been prepared (near Kisangani in the DRC). They found that SIV was indeed present in these chimpanzees, but the strains circulating there were phylogenetically distinct from all known strains of HIV-1.¹⁶ In other words, the chimpanzees in that area carried the wrong virus. They could not have been the source of the pandemic.

The molecular clock evidence described earlier also undermines the vaccine theory. If HIV-1 group M had entered humans via a vaccination campaign in the late 1950s, the virus would have had only a few years to diversify before the earliest known samples from 1959-1960. But those samples already show considerable genetic diversity, consistent with decades of prior circulation, not a few years. The scientific consensus is that the pandemic originated from natural human-primate contact, most likely through bushmeat hunting and butchering, which would have created ample opportunity for blood-to-blood exposure to SIVcpz.

Bushmeat and the Mechanics of Spillover

Hunting, butchering, and preparing wild primates for food remains common in parts of central and West Africa. This practice creates the most plausible route for SIV transmission to humans: a hunter who cuts himself while butchering an infected primate exposes his bloodstream directly to the animal’s blood. Given how many primate species carry SIV and how prevalent infection is in wild populations, such exposures have probably occurred countless times over centuries. The question is not why a spillover happened but why the pandemic-causing one happened when and where it did.

The answer likely involves urbanization. In rural settings, a person who contracted SIV from an animal might have passed it to a few people in a small village before the chain of transmission died out. The colonial-era growth of cities like Kinshasa created a new environment: dense populations, changing sexual networks, and reuse of unsterilized medical equipment in clinics treating sexually transmitted infections and other diseases. These conditions gave the virus the opportunity to spread beyond small clusters and into a sustained epidemic.

Ongoing Exposure and Future Risk

Cross-species transmission from primates to humans is not purely historical. A study of HIV-seronegative Cameroonians who had significant exposure to wild primates found that serological reactivity to SIV correlated with the level of primate contact. One individual showed strong antibody responses and weak cellular immune responses to a particular SIV strain, suggesting actual infection or very close exposure.¹⁷ This means that people in regions where bushmeat hunting is practiced are still being exposed to SIV, and that new spillover events, while unlikely to produce another pandemic given modern surveillance, remain possible.

The sheer diversity of SIV in the wild makes this a concern worth taking seriously. With more than 40 known SIV lineages in African primates, the reservoir of potential zoonotic viruses is large.¹ Most of these viruses would face significant barriers to adapting to human cells, and most exposures would lead nowhere. But the history of HIV itself demonstrates that low-probability events can have enormous consequences when conditions align. Surveillance of at-risk populations in Africa, particularly hunters and people living near primate habitats, remains an important part of pandemic preparedness. The lesson of HIV’s origin is not that we failed to prevent a one-time event but that zoonotic crossings are an ongoing feature of the relationship between humans and the viruses carried by their closest animal relatives.

How Ancient the Relationship Really Is

The popular image of HIV as a “new” virus is only true from a human perspective. The lentiviruses to which HIV belongs have been infecting primates for far longer than molecular clock estimates of SIV’s age in African monkeys would suggest. The discovery of endogenous lentivirus sequences in the genomes of two lemur species from Madagascar points to an association stretching back at least 14 million years, since that is roughly when Malagasy primates became geographically isolated from the African mainland.³ Endogenous retroviruses are fossils, essentially: bits of viral DNA that got permanently incorporated into an animal’s genome and were passed down through the generations. Finding lentiviral fossils in lemur DNA means that a lentivirus successfully infected the germ cells of a lemur ancestor millions of years ago.

The fact that two different lemur species carry independent lentiviral insertions indicates this was not a one-off event but a recurring phenomenon.⁴ The implication is that primate lentiviruses are much older and more broadly distributed than anyone assumed before the genomic era. HIV is the latest chapter in a very long story of viruses and primates coexisting, swapping hosts, and occasionally tipping into pathogenicity when conditions change. The pandemic arose not because something unprecedented happened but because a familiar biological process, viral spillover between primate species, landed in a host that had no evolutionary preparation for it, at a time when urbanization and global travel could carry the consequences worldwide.